Hims & Hers Health, Inc.

HIMS Healthcare Drug Manufacturers Specialty & Generic

Hims & Hers Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 59.0% from fiscal 2024.

Revenue
+38.3%
EPS
−294.7%
Free cash flow
+5.09%
Total debt
+40.8%

Quarter to June 2026, against a year earlier

24.11 2.55 −9.56%
Market cap
$5.6B
P/E
0.0×
Fwd P/E
−49.4×
Dividend yield
—
F-score
4/9
Altman Z
4.10
Beneish M
n/a
Dividend safety
n/a

Hims & Hers Health, Inc. (HIMS) Book value per share

Alert me on Book value per share

Hims & Hers Health, Inc.'s book value per share at the end of fiscal 2025 was 2.4×, up 8.92% from 2.2× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 1.4×. Over the past ten years it has ranged from −4.2× (fiscal 2020) to 7.4× (fiscal 2019); the current reading is higher than 82% of that period. Hims & Hers Health, Inc. ranks 40th of 84 Drug Manufacturers Specialty & Generic companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 2.4× 8.92%
FY2024 2.2× 34.33%
FY2023 1.6× 7.81%
FY2022 1.5× 0.00%
FY2022 1.5× (14.91%)
FY2021 1.8× 0.00%
FY2021 1.8× —
FY2020 −4.2× —
FY2020 2.9× 1,927.75%
FY2019 0.1× (98.06%)

Quarterly newest first

Period Book value per share Change
Jun 2026 1.4× (28.43%)
Mar 2026 2.0× (18.75%)
Dec 2025 2.4× (6.32%)
Sep 2025 2.6× 2.35%
25 more quarters

Against its own ten years

Low −4.2× High 7.4×
Ten-year median 1.8×
Current reading's percentile 82

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on HIMS